223 related articles for article (PubMed ID: 15782090)
1. Dorsal pancreatic duct dominance in pancreaticobiliary maljunction.
Kamisawa T; Egawa N; Nakajima H; Matsukawa M
Pancreas; 2005 Apr; 30(3):e60-3. PubMed ID: 15782090
[TBL] [Abstract][Full Text] [Related]
2. Pancreatobiliary disorders associated with pancreaticobiliary maljunction.
Kamisawa T; Honda G; Kurata M; Tokura M; Tsuruta K
Dig Surg; 2010; 27(2):100-4. PubMed ID: 20551651
[TBL] [Abstract][Full Text] [Related]
3. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of accessory pancreatic duct.
Kamisawa T; Takuma K; Tabata T; Egawa N
World J Gastroenterol; 2010 Sep; 16(36):4499-503. PubMed ID: 20857518
[TBL] [Abstract][Full Text] [Related]
5. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
Funabiki T; Matsubara T; Miyakawa S; Ishihara S
Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
[TBL] [Abstract][Full Text] [Related]
6. Pancreas divisum in pancreaticobiliary maljunction.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2008; 55(81):249-53. PubMed ID: 18507118
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
8. [Function of the accessory pancreatic duct in the pancreaticobiliary maljunction].
Kamisawa T; Egawa N; Ishiwata J; Okamoto A
Nihon Shokakibyo Gakkai Zasshi; 1997 Sep; 94(9):585-90. PubMed ID: 9311236
[TBL] [Abstract][Full Text] [Related]
9. Pancreaticobiliary maljunction.
Kamisawa T; Takuma K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K; Sasaki T
Clin Gastroenterol Hepatol; 2009 Nov; 7(11 Suppl):S84-8. PubMed ID: 19896105
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of pancreatic juice reflux in pancreaticobiliary maljunction: A fluid dynamics model experiment.
Fukuzawa H; Kajihara K; Tajikawa T; Aoki K; Ajiki T; Maeda K
J Hepatobiliary Pancreat Sci; 2020 May; 27(5):265-272. PubMed ID: 31943809
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic excision of the gallbladder and bile duct for patients with pancreaticobiliary maljunction.
Kobayashi S; Asano T; Yamasaki M; Kenmochi T; Saigo K; Ochiai T
Arch Surg; 2001 Jul; 136(7):759-63. PubMed ID: 11448385
[TBL] [Abstract][Full Text] [Related]
12. Pancreaticobiliary maljunction and biliary cancer.
Kamisawa T; Kuruma S; Tabata T; Chiba K; Iwasaki S; Koizumi S; Kurata M; Honda G; Itoi T
J Gastroenterol; 2015 Mar; 50(3):273-9. PubMed ID: 25404143
[TBL] [Abstract][Full Text] [Related]
13. Elevated bile amylase level without pancreaticobiliary maljunction is a risk factor for gallbladder carcinoma.
Fujimoto T; Ohtsuka T; Nakashima Y; Gotoh Y; Date K; Mori Y; Sadakari Y; Takahata S; Oda Y; Nakamura M
J Hepatobiliary Pancreat Sci; 2017 Feb; 24(2):103-108. PubMed ID: 28002646
[TBL] [Abstract][Full Text] [Related]
14. A case of pancreaticobiliary maljunction with a connecting duct without a long common channel.
Kikuyama M; Kamisawa T; Kuruma S; Chiba K; Koizumi S; Tabata T; Honda G
Clin J Gastroenterol; 2017 Apr; 10(2):196-199. PubMed ID: 28229343
[TBL] [Abstract][Full Text] [Related]
15. Hilar cholangiocarcinoma accompanied by pancreaticobiliary maljunction without bile duct dilatation 20 years after cholecystectomy: report of a case.
Yamada S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Kanamoto M; Hanaoka J; Iwahashi S; Saito Y; Ishibashi H
J Med Invest; 2013; 60(1-2):169-73. PubMed ID: 23614928
[TBL] [Abstract][Full Text] [Related]
16. Cancer of the gallbladder associated with pancreaticobiliary maljunction without bile duct dilatation in a european patient.
Tuech JJ; Pessaux P; Aube C; Regenet N; Cervi C; Bergamaschi R; Arnaud JP
J Hepatobiliary Pancreat Surg; 2000; 7(3):336-8. PubMed ID: 10982637
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the accessory pancreatic duct.
Kamisawa T; Egawa N; Nakajima H; Sakaki N; Tsuruta K; Okamoto A
Hepatogastroenterology; 2003; 50(54):2196-8. PubMed ID: 14696497
[TBL] [Abstract][Full Text] [Related]
18. Recent advances and problems in the management of pancreaticobiliary maljunction: feedback from the guidelines committee.
Kamisawa T; Ando H; Shimada M; Hamada Y; Itoi T; Takayashiki T; Miyazaki M
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):87-92. PubMed ID: 23798483
[TBL] [Abstract][Full Text] [Related]
19. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
20. Classification of pancreaticobiliary maljunction and its clinical features in adults.
Yoshimoto K; Kamisawa T; Kikuyama M; Kuruma S; Chiba K; Igarashi Y
J Hepatobiliary Pancreat Sci; 2019 Dec; 26(12):541-547. PubMed ID: 31633314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
